The neurosteroid dehydroepiandrosterone could improve somatic cell reprogramming

Cell Biology International

Volumn 35, Issue 10, 2011, Pages 1037-1041

  Shoae Hassani, Alireza ^a   Sharif, Shiva ^b   Verdi, Javad ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Dehydroepiandrosterone (DHEA); Induced pluripotent stem cells (iPSC); P53; Reprogramming; Stem cell; Steroid

Indexed keywords

PRASTERONE; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LEVEL; CELL RENEWAL; CELL VIABILITY; GENE EXPRESSION; HORMONE ACTION; KLF4 GENE; NUCLEAR REPROGRAMMING; OCT4 GENE; ONCOGENE C MYC; PLURIPOTENT STEM CELL; SOMATIC CELL; TRANSGENE; TUMOR SUPPRESSOR GENE;

ADJUVANTS, IMMUNOLOGIC; APOPTOSIS; DEHYDROEPIANDROSTERONE; HUMANS; MODELS, THEORETICAL; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80054983103     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20100927     Document Type: Article

References (77)

1. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005;6:635-45.
2. Angel M, Yanik MF. Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS One 2010;5:e11756.
3. Asahara T, Murohara T, Sullivan A. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-67.
4. Bastianetto S, Ramassamy C, Poirier J, Quirion R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Mol Brain Res 1999;66:35-41.
5. Baulieu EE. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Psychoneuroendocrinology 1998;2:963-87.
6. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999;283:534-7.
7. Boyer LA, Lee TI, Cole MF. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005;122:947-56.
8. Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow to brain:expression of neuronal phenotypes in adult mice. Science 2000;290:1775-9.
9. Bru T, Clarke C, McGrew MJ, Sang HM, Wilmut I. Rapid induction of pluripotency genes after exposure of human somatic cells to mouse ES cell extracts. Exp Cell Res 2008;15:2634-42.
10. Byrne JA, Pedersen DA, Clepper LL, Nelson M, Sanger WG. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 2007;450:497-502.
11. Chang BD, Watanabe K, Broude EV. Effects of p21waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci USA 2000;97:4291-6.
12. Chang DC, Broudy E, Dokmanovic D. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 1999;59:3761-7.
13. Cho Y, Gorina S, Jeffrey P, Pavletich NP. Understanding tumorigenic mutations. Science 1994;265:346-55.
14. Compagnone NA, Mellon SH. Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc Natl Acad Sci USA 1998;95:4678-83.
15. Cowan CA, Atienza J, Melton DA, Eggan K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005;309:1369-73.
16. Dashwood RH, Myzak MC, Ho E. Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? Carcinogenesis 2006;27:344-9.
17. Deng J, Shoemaker R, Xie B. Targeted bisulfate sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 2009;27:353-60.
18. Eilertsen KJ, Power RA, Harkins LL, Misica P. Targeting cellular memory to reprogram the epigenome, restore potential, and improve somatic cell nuclear transfer. Anim Rep Sci 2007;98:129-46.
19. Fernandez PC, Frank SR, Wang L. Genomic targets of the human c-Myc protein. Genes Dev 2003;17:1115-29.
20. Ferrari G, Cusella-De Angelis G, Coletta M. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528-30.
21. Green JE, Shibata MA, Shibata E. 2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. Cancer Res 2001;61:7449-55.
22. Griswold MD, Kim JS. Site-specific methylation of the promoter alters deoxyribonucleic acidprotein interactions and prevents folliclestimulating hormone receptor gene transcription. Biol Reprod 2001;64:602-10.
23. Gussoni E, Soneoka Y, Strickland CD. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999;401:390-4.
24. Hainaut P, Hollstein M. p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 2000;77:81-137.
25. Han J, Sidhu KS. Current concepts in reprogramming somatic cells to pluripotent state. Curr Stem Cell Res Ther 2008;3:66-74.
26. Hanna J, Saha K, Pando B. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009;462:595-601.
27. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the antiapoptotic survivin gene by wild-type p53. J Biol Chem 2002;277:3247-57.
28. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009;460:1132-5.
29. Hupp TR, Meek DW, Midgley CA, Lane DP. Regulation of the specific DNA binding function of p53. Cell 1992;71:875-86.
30. Ichida J, Blanchard J, Lam K. A small molecule inhibitor of TGF-beta signaling replaces Sox2 in reprogramming by inducing Nanog. Cell Stem Cell 2009;5:491-503.
31. Jia F, Wilson KD, Sun N. A non-viral mini circle vector for deriving human iPS cells. Nat Methods 2008;7:197-9.
32. Kalimi M, Shafagoj Y, Loria R, Padgett D, Regelson W. Anti glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem 1994;131:99-104.
33. Karishma KK, Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci 2002;16:445-53.
34. Kastan MB, Canman CE, Leonard CJ. p53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 1995;14:3-15.
35. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB. Linking the p53 tumor suppressor pathway to somatic cell reprogramming. Nature 2009;460:1140-4.
36. Kern SC, Kinzler KW, Bruskin A. Identification of p53 as a sequencespecific DNA-binding protein. Science 1991;252:1708-11.
37. Kim JB, Greber B, Arauzo Bravo MJ. Direct reprogramming of human neural stem cells by OCT4. Nature 2009a;461:649-53.
38. Kim JB, Sebastiano V, Wu GM. Oct4-induced pluripotency in adult neural stem cells. Cell 2009b;136:411-9.
39. Krause DS, Theise ND, Collector MI. Multi-organ, multilineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105:369-77.
40. Labrie F, Luu-The V, Labrie C, Simard J. DHEA and its transformation into androgens and estrogens in peripheral target tissues:intracrinology. Front Neuroendocrinol 2001;22:185-212.
41. Lagasse E, Connors H, Al-Dhalimy M. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-34.
42. Li H, Collado M, Villasante A, Strati K, Ortega S. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009;460:1136-9.
43. Lin T, Chao C, Saito S. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005;7:165-71.
44. Loh YH, Wu Q, Chew JL. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Gen 2006;38:431-40.
45. Marion RM, Strati K, Li H, Murga M, Blanco R. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009;460:1149-53.
46. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000;290:1779-82.
47. Mikkelsen T, Hanna S, Zhang X. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008;454:49-55.
48. Miyamoto K, Tsukiyama T, Yang Y, Li N, Minami N. Cell-free extracts from mammalian oocytes partially induce nuclear reprogramming in somatic cells. Biol Rep 2009;80:935-43.
49. Miyashita T, Reed J. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-9.
50. Niwa H, Miyazaki JI, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Gen 2000;24:372-6.
51. Oberlander TF, Weinberg J, Papsdorf M. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 2008;3:97-106.
52. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax that accelerates programmed cell death. Cell 1993;74:609-19.
53. Orlic D, Kajstura J, Chimenti S. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
54. Petersen BE, Bowen WC, Patrene KD. Bone marrow as a potential source of hepatic oval cells. Science 1999;284:1168-70.
55. Rao KV, Johnson WD, Bosland MC. Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone. Cancer Res 1999;59:3084-9.
56. Rideout WM, Eggan K, Jaenisch R. Nuclear cloning and epigenetic reprogramming of the genome. Science 2001;293:1093-8.
57. Risdon G, Cope J, Bennett M. Mechanisms of chemoprevention by dietary dehydroisoandrosterone. Inhibition of lymphopoiesis. Am J Pathol 1990;136:759-69.
58. Risdon G, Kumar V, Bennett M. Differential effects of dehydroepiandrosterone (DHEA) on murine lymphopoiesis and myelopoiesis. Exp Hematol 1991;19:128-31.
59. Rowland BD, Bernards R, Peeper DS. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 2005;7:1074-82.
60. Schwartz A, Pashko L. Mechanism of cancer prevention action of DHEA. Ann NY Acad Sci 1995;774:180-6.
61. Shih CC, Mamelak A, LeBon T, Forman SJ. Hematopoietic potential of neural stem cells. Nature Med 2002;8:535-6.
62. Soldner F, Hockemeyer D, Beard C. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009;136:964-77.
63. Stadtfeld M, Utikal J, Weir G. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010;465:175-81.
64. Sugrue MM, Shin DY, Lee SW, Aaronson SA. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci USA 1997;94:9648-53.
65. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76.
66. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72.
67. Takashima Y, Era T, Nakao K. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 2007;129:1377-88.
68. Taranger CK, Noer A, Sørensen AL, Hakelien AM, Boquest AC. Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol Biol Cell 2005;16:5719-5735.
69. Utikal J, Polo JM, Stadtfeld M. Immortalization eliminates a road block during cellular reprogramming into iPS cells. Nature 2009;460:1145-8.
70. Vousden KH, Lu X. Live or let die: the cell's response p53. Nat Rev Cancer 2002;2:594-604.
71. Wernig M, Lengner CJ, Hanna J. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotech 2008;26:916-24.
72. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-4.
73. Xu HJ, Zhou Y, Ji W. Re-expression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene 1997;15:2589-96.
74. Yu J, Vodyanik MA, Smuga-Otto K. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-20.
75. Zhang Y, Fatima N, Dufau ML. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Mol Cell Biol 2005;25:7929-39.
76. Zhou H, Wu S, Joo JY. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009;4:381-4.
77. Zhu JQ, Zhu L, Liang XW. Demethylation of LHR in Dehydroepiandrosterone induced mouse model of polycystic ovary syndrome. Mol Hum Reprod 2010;16:260-6.